Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Bellevue Life Sciences Acquisition's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Bellevue Life Sciences Acquisition (BLAC) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
Competitors
2
Named by the company
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
-69.44 %
Q2 2026
Net Margin
-318.07 %
Q2 2026

Key Findings: Bellevue Life Sciences Acquisition vs Its Competitors

  • TTM: Trailing 12-month revenue of 2M vs -M combined for its competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-30.2% annualized vs trailing 12 months).
  • Peer revenue share: Bellevue Life Sciences Acquisition accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

BLAC Sales vs. its Competitors, Q2 2026

Bellevue Life Sciences Acquisition generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BLAC/competitors
https://api.csimarket.com/api/v1/companies/BLAC/relationships
https://api.csimarket.com/api/v1/companies/BLAC/similar
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API

For context: the Medical Equipment & Supplies industry grew revenue 14.4% year over year, combined, vs -69.4% for Bellevue Life Sciences Acquisition. Bellevue Life Sciences Acquisition's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Market Share of the Peer Group, Q2 2026

100%market share
  • Bellevue Life Sciences Acquisition100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Bellevue Life Sciences Acquisition and its 2 competitors.

See Bellevue Life Sciences Acquisition's full market share breakdown »

BLAC Stock Performance relative to its Competitors

BLAC Competitors (weighted) Percent change over the selected range

Bellevue Life Sciences Acquisition's Comment on Competition and Industry Peers

RMC has developed a nationwide sales network and logistics system in South Korea, which supports its distribution of products such as the Chikai Guide Wire from Asahi Intecc, used in neurovascular endovascular therapy. The company operates in a competitive environment that includes pharmaceutical and biotechnology firms as well as public and private research institutions. Competitors may achieve faster regulatory approvals, secure patent protections, or develop drugs with improved efficacy, convenience, cost-effectiveness, or safety. Additionally, competitors may have advantages in manufacturing and marketing their products.

Bellevue Life Sciences Acquisition's Competitors Named by the Company

Competitive relationships identified from Bellevue Life Sciences Acquisition reports and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Asahi Intecc Company report 85% 2022 to 2026 3
RMC Company report 85% 2022 to 2026 3
Competitor Evidence Detail

Company report basis, confidence, active dates and source counts for Bellevue Life Sciences Acquisition's named competitors require a Commercial License.

Methodology: see Methodology: Peer & Competitor Identification, Sourcing.

Get the full CSIMarket dataset: Subscribe API Connect Your AI